INO

Inovio Pharmaceuticals Inc.

Price

$0.71

return (12m)

-50.04%

p/e

-0.54

p/bv

7.50

DIVIDEND YIELD

0.00%

INO price

Inovio Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-41.44%

3 months

-37.33%

1 year

-50.04%

2 years

-92.47%

5 years

-99.32%

10 years

-99.38%

Fundamentals INO

Valuation

P/E

-0.54

Sector -3.98

Industry -3.98

P/BV

7.50

Sector 2.00

Industry 2.00

P/Revenue (PSR)

Sector -4.41

Industry -4.41

EV/EBITDA

-0.37

Sector -245.01

Industry -245.01

EV/EBIT

-0.36

Sector -666.51

Industry -666.51

P/EBITDA

-0.54

Sector -4.07

Industry -4.07

P/EBIT

-0.52

Sector -4.24

Industry -4.24

P/Total Assets

0.91

Sector 1.40

Industry 1.40

P/Net Current Assets

-10.67

Sector -11.65

Industry -11.65

P/Working Capital

29.96

Sector -10.95

Industry -10.95

EPS

-1.23

Sector -2.20

Industry -2.20

BVPS

0.09

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.05%

Industry 36.05%

EBITDA Margin

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

0.00%

Sector -38.74%

Industry -38.74%

Net Profit Margins

0.00%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-1,399.18%

Sector -66.41%

Industry -66.41%

ROA

-170.61%

Sector -66.55%

Industry -66.55%

ROIC

-181.72%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.04

Sector 2.90

Industry 2.90

Net Debt / EBITDA

1.78

Sector -14.63

Industry -14.63

Net Debt / EBIT

1.72

Sector -7.24

Industry -7.24

Net Debt / Equity

-6.21

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

0.00

Sector -0.02

Industry -0.02

Equity/Assets

0.12

Sector 0.42

Industry 0.42

Liabilities/Assets

0.88

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-22.49%

Sector -

Industry -

Fundamentals INO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
INO	-0.54	7.50	-1,399.18%	0.00%	$45.54 M	0.00%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/27/2017	10/16/2017	0.82800000
Dividends	08/29/2017	09/15/2017	0.82800000

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

Average Investor10 user rating

5.0 (3 people)

United States

43 years

Founded: 1983

1998

Time since IPO - 28 years

190

Employees

Inovio Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $45.54 million, with shareholders equity totaling $6.07 million.

The company employs approximately 190 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Inovio Pharmaceuticals Inc. reported $- in revenue, generating net income of $-84.93 million.

Key financial metrics include a P/E ratio of -0.54, a price-to-book (P/B) ratio of 7.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INO.

Market cap

$45.54 million

Net worth

$6.07 million

$6,070,000.00

Assets

$49.78 million

$49,780,000.00

Total Shares Outstanding

69.00 million

69,000,000

Average Daily Trading Volume

$2.49 million

$2,491,051.08

Sector

Health Care

Industry

Biotechnology

INO

INO revenue and profits

Financial Results INO

DRAG THE FRAME TO SEE MORE DATA

INO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$847.31 21,88% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$232.10 50,34% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$252.98 55,77% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$245.58 30,93% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$127.32 66,98% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$154.46 6,01% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$46.60 0,09% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$847.31 21,88% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$232.10 50,34% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$252.98 55,77% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$245.58 30,93% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$127.32 66,98% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$154.46 6,01% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$46.60 0,09% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Inovio Pharmaceuticals (INO) today?

A cotação de Inovio Pharmaceuticals (INO) hoje está em US$ 0.71, com uma variação de -50.04% em relação ao último ano. A cotação de Inovio Pharmaceuticals (INO) iniciou o ano negociando na casa dos US$ 1.74 e hoje está em US$ 0.71. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Inovio Pharmaceuticals (INO) e dados de ações do Ibovespa e mercados internacionais.

Quando Inovio Pharmaceuticals (INO) paga dividendos?

Inovio Pharmaceuticals (INO) não distribuiu dividendos no último ano.

Is Inovio Pharmaceuticals (INO) a good investment?

Atualmente, Inovio Pharmaceuticals (INO) está cotada a US$ 0.71, com um P/L de -0.54, representando um desvio de -95% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -50.04 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -50.04%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Inovio Pharmaceuticals (INO) stock?

Investir em ações de Inovio Pharmaceuticals (INO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Inovio Pharmaceuticals (INO) yield today?

A rentabilidade de Inovio Pharmaceuticals (INO) foi de -41.44% no último mês, -50.04% no último ano e -99.32% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Inovio Pharmaceuticals (INO) hoje, o investimento total seria de US$ 71.45, com base na cotação atual de US$ 0.71.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 35.69
Em 5 anos: US$ 0.49
Em 10 anos: US$ 0.44

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INO

Inovio Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

United States

43 years

1998

190

PROFIT X PRICE INO

Financial Results INO

INO cash flow

Asset, Revenue and Profit Growth - INO

INO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions